365 related articles for article (PubMed ID: 37052520)
21. Retinoblastoma family proteins: insights gained through genetic manipulation of mice.
Wikenheiser-Brokamp KA
Cell Mol Life Sci; 2006 Apr; 63(7-8):767-80. PubMed ID: 16465443
[TBL] [Abstract][Full Text] [Related]
22. Lineage plasticity in cancer: a shared pathway of therapeutic resistance.
Quintanal-Villalonga Á; Chan JM; Yu HA; Pe'er D; Sawyers CL; Sen T; Rudin CM
Nat Rev Clin Oncol; 2020 Jun; 17(6):360-371. PubMed ID: 32152485
[TBL] [Abstract][Full Text] [Related]
23. The molecular basis of cancer suppression by the retinoblastoma gene.
Lee WH
Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
[TBL] [Abstract][Full Text] [Related]
24. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Biswas A; De S
Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
[TBL] [Abstract][Full Text] [Related]
25. The genetics of retinoblastoma. Relevance to the patient.
Gallie BL; Dunn JM; Chan HS; Hamel PA; Phillips RA
Pediatr Clin North Am; 1991 Apr; 38(2):299-315. PubMed ID: 2006079
[TBL] [Abstract][Full Text] [Related]
26. Differential gene expression profile of retinoblastoma compared to normal retina.
Ganguly A; Shields CL
Mol Vis; 2010 Jul; 16():1292-303. PubMed ID: 20664703
[TBL] [Abstract][Full Text] [Related]
27. Retinoblastoma tumor suppressor and genome stability.
Zheng L; Lee WH
Adv Cancer Res; 2002; 85():13-50. PubMed ID: 12374284
[TBL] [Abstract][Full Text] [Related]
28. Cellular Plasticity in Cancer.
Yuan S; Norgard RJ; Stanger BZ
Cancer Discov; 2019 Jul; 9(7):837-851. PubMed ID: 30992279
[TBL] [Abstract][Full Text] [Related]
29. ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers.
Xu Y; Wang Z; Sjöström M; Deng S; Wang C; Johnson NA; Gonzalez J; Li X; Metang LA; Tirado CR; Mukherji A; Wainwright G; Yu X; Yang Y; Barnes S; Hofstad M; Zhu H; Hanker A; He HH; Chen Y; Wang Z; Raj G; Arteaga C; Feng F; Wang Y; Wang T; Mu P
bioRxiv; 2023 Oct; ():. PubMed ID: 37961351
[TBL] [Abstract][Full Text] [Related]
30. RB1 loss triggers dependence on ESRRG in retinoblastoma.
Field MG; Kuznetsoff JN; Zhang MG; Dollar JJ; Durante MA; Sayegh Y; Decatur CL; Kurtenbach S; Pelaez D; Harbour JW
Sci Adv; 2022 Aug; 8(33):eabm8466. PubMed ID: 35984874
[TBL] [Abstract][Full Text] [Related]
31. BET Inhibition Sensitizes Immunologically Cold Rb-Deficient Prostate Cancer to Immune Checkpoint Blockade.
Olson BM; Chaudagar K; Bao R; Saha SS; Hong C; Li M; Rameshbabu S; Chen R; Thomas A; Patnaik A
Mol Cancer Ther; 2023 Jun; 22(6):751-764. PubMed ID: 37014264
[TBL] [Abstract][Full Text] [Related]
32. The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity.
Storck WK; May AM; Westbrook TC; Duan Z; Morrissey C; Yates JA; Alumkal JJ
Front Endocrinol (Lausanne); 2022; 13():926585. PubMed ID: 35909568
[TBL] [Abstract][Full Text] [Related]
33. P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation.
Papavassiliou KA; Sofianidi AA; Gogou VA; Anagnostopoulos N; Papavassiliou AG
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473726
[TBL] [Abstract][Full Text] [Related]
34. Mutation of the retinoblastoma tumor suppressor gene sensitizes cancers to mitotic inhibitor induced cell death.
Zhao J; Zhang Z; Liao Y; Du W
Am J Cancer Res; 2014; 4(1):42-52. PubMed ID: 24482737
[TBL] [Abstract][Full Text] [Related]
35. More epigenetic hits than meets the eye: microRNAs and genes associated with the tumorigenesis of retinoblastoma.
Reis AH; Vargas FR; Lemos B
Front Genet; 2012; 3():284. PubMed ID: 23233862
[TBL] [Abstract][Full Text] [Related]
36. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
Arima Y; Inoue Y; Shibata T; Hayashi H; Nagano O; Saya H; Taya Y
Cancer Res; 2008 Jul; 68(13):5104-12. PubMed ID: 18593909
[TBL] [Abstract][Full Text] [Related]
37. Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function.
Markey MP; Bergseid J; Bosco EE; Stengel K; Xu H; Mayhew CN; Schwemberger SJ; Braden WA; Jiang Y; Babcock GF; Jegga AG; Aronow BJ; Reed MF; Wang JY; Knudsen ES
Oncogene; 2007 Sep; 26(43):6307-18. PubMed ID: 17452985
[TBL] [Abstract][Full Text] [Related]
38. Coupled down-regulation of the RB retinoblastoma and c-myc genes antecedes cell differentiation: possible role of RB as a "status quo" gene.
Yen A; Chandler S; Forbes ME; Fung YK; T'Ang A; Pearson R
Eur J Cell Biol; 1992 Apr; 57(2):210-21. PubMed ID: 1511698
[TBL] [Abstract][Full Text] [Related]
39. Chromatin remodeling protein HELLS is critical for retinoblastoma tumor initiation and progression.
Zocchi L; Mehta A; Wu SC; Wu J; Gu Y; Wang J; Suh S; Spitale RC; Benavente CA
Oncogenesis; 2020 Feb; 9(2):25. PubMed ID: 32071286
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis.
Kareta MS; Gorges LL; Hafeez S; Benayoun BA; Marro S; Zmoos AF; Cecchini MJ; Spacek D; Batista LF; O'Brien M; Ng YH; Ang CE; Vaka D; Artandi SE; Dick FA; Brunet A; Sage J; Wernig M
Cell Stem Cell; 2015 Jan; 16(1):39-50. PubMed ID: 25467916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
